ESR1 and neuroblastoma: Earlier work in cell culture demonstrated that MAPK phosphorylates ERα at S118 following IGF-1 treatment (Kato et al., 1995), and recent work from our laboratory in a neuroblastoma cell line supports the role of neuroestrogens in activating the MAPK pathway in conjunction with IGF-1R (Pollard and Daniel, 2019).